We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VR
351
DELISTED
Validus Hold Ltd
VR
| $24.9M | 0.07% |
530,819
+40,612
| +8% | +$2.01M |
|
|
WCG
352
DELISTED
Wellcare Health Plans, Inc.
WCG
| $24.7M | 0.07% |
122,881
+29,225
| +31% | +$5.66M |
|
353
Simon Property Group
SPG
$74.5B
| $24.6M | 0.07% |
143,400
+34,600
| +32% | +$5.62M |
|
354
Align Technology
ALGN
$12B
| $24.6M | 0.07% |
110,630
+92,000
| +494% | +$20.9M |
|
355
CBRE Group
CBRE
$40.8B
| $24.2M | 0.07% |
558,557
+304,492
| +120% | +$12.6M |
|
356
iShares Russell 1000 Growth ETF
IWF
$122B
| $24M | 0.06% |
714,000
-686,400
| -49% | -$22.5M |
|
|
MNK
357
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $24M | 0.06% |
+1,064,134
| New | +$28.5M |
|
|
HDS
358
DELISTED
HD Supply Holdings, Inc.
HDS
| $24M | 0.06% |
599,677
+521,738
| +669% | +$19.2M |
|
359
PENN Entertainment
PENN
$2.74B
| $23.9M | 0.06% |
761,952
+302,409
| +66% | +$8.16M |
|
360
Portland General Electric
POR
$6.02B
| $23.9M | 0.06% |
523,367
+345,153
| +194% | +$16.3M |
|
361
Eli Lilly
LLY
$1.07T
| $23.8M | 0.06% |
282,227
+80,932
| +40% | +$6.89M |
|
362
Principal Financial Group
PFG
$23.6B
| $23.7M | 0.06% |
336,271
-35,800
| -10% | -$2.47M |
|
|
CTLT
363
DELISTED
CATALENT, INC.
CTLT
| $23.6M | 0.06% |
574,851
-83,688
| -13% | -$3.41M |
|
364
Advanced Energy
AEIS
$12.2B
| $23.6M | 0.06% |
349,870
-66,623
| -16% | -$5.37M |
|
365
DaVita
DVA
$15.1B
| $23.4M | 0.06% |
324,224
-47,800
| -13% | -$2.94M |
|
366
Scotiabank
BNS
$106B
| $23.3M | 0.06% |
359,945
+49,191
| +16% | +$3.19M |
|
367
Hanover Insurance
THG
$7.63B
| $23.1M | 0.06% |
213,327
-48,028
| -18% | -$4.96M |
|
|
TMX
368
DELISTED
Terminix Global Holdings, Inc.
TMX
| $23.1M | 0.06% |
671,293
-33,194
| -5% | -$1.07M |
|
369
Domino's
DPZ
$11B
| $23M | 0.06% |
121,469
-488,700
| -80% | -$90.5M |
|
370
InterDigital
IDCC
$6.68B
| $22.9M | 0.06% |
300,228
+119,000
| +66% | +$8.89M |
|
371
Dick's Sporting Goods
DKS
$18.4B
| $22.6M | 0.06% |
786,267
-251,987
| -24% | -$6.95M |
|
|
VAR
372
DELISTED
Varian Medical Systems, Inc.
VAR
| $22.5M | 0.06% |
202,459
+15,400
| +8% | +$1.66M |
|
373
Caesars Entertainment
CZR
$6.1B
| $22.3M | 0.06% |
672,234
+213,567
| +47% | +$6.2M |
|
|
AZPN
374
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $22.3M | 0.06% |
336,293
-538
| -0.2% | -$35.6K |
|
375
J.M. Smucker
SJM
$12.6B
| $22.1M | 0.06% |
178,012
+161,900
| +1,005% | +$18M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.